Conference
Antifibrotic Drug Development Summit 2024
Nov 19, 2024 - Nov 21, 2024
Hilton Boston Back Bay
An important event devoted to furthering the development of antifibrotic medications is the Annual AFDD Summit 2024, which will be held in Boston, Massachusetts, from November 19–21. Leading authorities, scholars, and businesspeople gather at this event to talk about the newest developments and treatment strategies in fibrosis research.
Insightful talks, workshops, and presentations on important subjects like drug discovery, preclinical models, and clinical trials will be held with participants. In order to hasten the creation of potent antifibrotic treatments, the summit seeks to promote cooperation and knowledge exchange among participants.
With a different setup of speakers from top associations, the AFDD Summit 2024 is a fundamental stage for systems administration and investigating new open doors in the field. Whether you are a specialist, clinician, or industry pioneer, this occasion vows to give significant experiences and associations with additional your work in antifibrotic drug improvement.
Speaker line up
Adam Freund
Arda Therapeutics
Founder and CEO
Andrew Whittle
Boehringer Ingelheim
Director, BD&L
Anil Karihaloo
Novo Nordisk
Sr Principal Res Scientist
Chan Whiting
Deciduous Therapeutics
Chief Scientific Officer
Christina Wenglén
AnaMar AB
Head of Research
About the Organiser
Hanson Wade LimitedHanson Wade specializes in structuring data and insights for drug discovery and development, focusing on emerging niches in the life sciences. They offer a range of products, including conferences, market intelligence, and data analysis tools, designed to facilitate safe and effective drug development. Their conferences bring together industry experts to share knowledge and foster collaborations in various fields, such as gene therapy, precision oncology, and protein degradation.
Day and Timing
Tuesday, Nov 19 - 21
Location
Hilton Boston Back Bay
Entry Fees
Paid
Frequency
Quarterly
Event Type
Conference
Duration
3 Days
Website
afdd-summit.comDay and Timing
Tuesday, Nov 19 - 21
Location
Hilton Boston Back Bay
Entry Fees
Paid
Frequency
Quarterly
Event Type
Conference
Duration
3 Days
Website
afdd-summit.comSpeaker line up
Adam Freund
Arda Therapeutics
Founder and CEO
Andrew Whittle
Boehringer Ingelheim
Director, BD&L
Anil Karihaloo
Novo Nordisk
Sr Principal Res Scientist
Chan Whiting
Deciduous Therapeutics
Chief Scientific Officer
Christina Wenglén
AnaMar AB
Head of Research
About the Organiser
Hanson Wade LimitedHanson Wade specializes in structuring data and insights for drug discovery and development, focusing on emerging niches in the life sciences. They offer a range of products, including conferences, market intelligence, and data analysis tools, designed to facilitate safe and effective drug development. Their conferences bring together industry experts to share knowledge and foster collaborations in various fields, such as gene therapy, precision oncology, and protein degradation.
More Events
Conference
9th Annual American Pharma Manufacturing and Outsourcing Summit
Nov 17, 2025 - Nov 18, 2025
Boston,USA
Conference
European Biomanufacturing Summit
Oct 22, 2025 - Oct 23, 2025
Dusseldorf, Germany
Conference
Pharma SFE SFA Summit & Awards
Oct 10, 2025
Cairo, Egypt
View All
Subscribe to our Newsletter!
Be the first to get exclusive offers and the latest news